GS
PROF
Gagnon Securities’s Profound Medical PROF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
1,749,913
+52,233
| +3% | +$308K | 2.1% | 21 |
|
|
2025
Q1 | $9.88M | Buy |
1,697,680
+45,149
| +3% | +$263K | 2.17% | 19 |
|
|
2024
Q4 | $12.4M | Buy |
1,652,531
+185,284
| +13% | +$1.39M | 2.5% | 17 |
|
|
2024
Q3 | $11.7M | Sell |
1,467,247
-41,274
| -3% | -$329K | 2.32% | 15 |
|
|
2024
Q2 | $12.7M | Sell |
1,508,521
-20,516
| -1% | -$172K | 2.85% | 9 |
|
|
2024
Q1 | $13M | Sell |
1,529,037
-12,539
| -0.8% | -$107K | 3.09% | 10 |
|
|
2023
Q4 | $13.1M | Sell |
1,541,576
-40,590
| -3% | -$345K | 3.14% | 9 |
|
|
2023
Q3 | $16.1M | Sell |
1,582,166
-22,974
| -1% | -$234K | 4.04% | 6 |
|
|
2023
Q2 | $20.9M | Sell |
1,605,140
-115,424
| -7% | -$1.5M | 4.34% | 5 |
|
|
2023
Q1 | $16M | Sell |
1,720,564
-57,641
| -3% | -$535K | 3.36% | 9 |
|
|
2022
Q4 | $19.4M | Buy |
1,778,205
+11,350
| +0.6% | +$124K | 4.28% | 5 |
|
|
2022
Q3 | $7.13M | Buy |
1,766,855
+439,323
| +33% | +$1.77M | 1.57% | 26 |
|
|
2022
Q2 | $9.68M | Buy |
1,327,532
+3,197
| +0.2% | +$23.3K | 2.03% | 21 |
|
|
2022
Q1 | $11.9M | Buy |
1,324,335
+246,978
| +23% | +$2.22M | 1.94% | 20 |
|
|
2021
Q4 | $12.1M | Buy |
1,077,357
+110,821
| +11% | +$1.24M | 1.81% | 25 |
|
|
2021
Q3 | $14.2M | Buy |
966,536
+165,691
| +21% | +$2.43M | 2.1% | 20 |
|
|
2021
Q2 | $13.1M | Buy |
800,845
+22,955
| +3% | +$376K | 1.86% | 21 |
|
|
2021
Q1 | $15.7M | Sell |
777,890
-43,306
| -5% | -$872K | 2.39% | 14 |
|
|
2020
Q4 | $16.9M | Buy |
821,196
+41,663
| +5% | +$857K | 2.69% | 13 |
|
|
2020
Q3 | $13.8M | Buy |
779,533
+47,818
| +7% | +$844K | 2.93% | 12 |
|
|
2020
Q2 | $12.4M | Sell |
731,715
-36,211
| -5% | -$613K | 3% | 13 |
|
|
2020
Q1 | $7.48M | Buy |
767,926
+71,116
| +10% | +$693K | 2.54% | 15 |
|
|
2019
Q4 | $7.63M | Buy |
+696,810
| New | +$7.63M | 1.67% | 25 |
|